These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

542 related items for PubMed ID: 35226830

  • 1. MicroRNA-200b-3p restrains gastric cancer cell proliferation, migration, and invasion via C-X-C motif chemokine ligand 12/CXC chemokine receptor 7 axis.
    Li D, Li Q.
    Bioengineered; 2022 Mar; 13(3):6509-6520. PubMed ID: 35226830
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Noxa inhibits oncogenesis through ZNF519 in gastric cancer and is suppressed by hsa-miR-200b-3p.
    Shi J, Ding F, Dai D, Song X, Wu X, Yan D, Han X, Tao G, Dai W.
    Sci Rep; 2024 Mar 19; 14(1):6568. PubMed ID: 38503887
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. CXCR7/CXCL12 axis is involved in lymph node and liver metastasis of gastric carcinoma.
    Xin Q, Zhang N, Yu HB, Zhang Q, Cui YF, Zhang CS, Ma Z, Yang Y, Liu W.
    World J Gastroenterol; 2017 May 07; 23(17):3053-3065. PubMed ID: 28533662
    [Abstract] [Full Text] [Related]

  • 6. Transcription factor PAX4 facilitates gastric cancer progression through interacting with miR-27b-3p/Grb2 axis.
    Zhang Y, Ding L, Ni Q, Tao R, Qin J.
    Aging (Albany NY); 2021 Jun 23; 13(12):16786-16803. PubMed ID: 34162761
    [Abstract] [Full Text] [Related]

  • 7. Long non-coding RNA PCED1B antisense RNA 1 promotes gastric cancer progression via modulating microRNA-215-3p / C-X-C motif chemokine receptor 1 axis.
    Ren J, Xu N, Zhou R, Huang F, Zhang H, Li W.
    Bioengineered; 2021 Dec 23; 12(1):6083-6095. PubMed ID: 34516330
    [Abstract] [Full Text] [Related]

  • 8. Silencing of long non-coding RNA HCP5 inhibits proliferation, invasion, migration, and promotes apoptosis via regulation of miR-299-3p/SMAD5 axis in gastric cancer cells.
    Yin D, Lu X.
    Bioengineered; 2021 Dec 23; 12(1):225-239. PubMed ID: 33371778
    [Abstract] [Full Text] [Related]

  • 9. CXCR7 as a chemokine receptor for SDF-1 promotes gastric cancer progression via MAPK pathways.
    Shi A, Shi H, Dong L, Xu S, Jia M, Guo X, Wang T.
    Scand J Gastroenterol; 2017 Dec 23; 52(6-7):745-753. PubMed ID: 28281844
    [Abstract] [Full Text] [Related]

  • 10. LncRNA MT1JP Suppresses Gastric Cancer Cell Proliferation and Migration Through MT1JP/MiR-214-3p/RUNX3 Axis.
    Xu Y, Zhang G, Zou C, Zhang H, Gong Z, Wang W, Ma G, Jiang P, Zhang W.
    Cell Physiol Biochem; 2018 Dec 23; 46(6):2445-2459. PubMed ID: 29742512
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. MicroRNA 520d-3p inhibits gastric cancer cell proliferation, migration, and invasion by downregulating EphA2 expression.
    Li R, Yuan W, Mei W, Yang K, Chen Z.
    Mol Cell Biochem; 2014 Nov 23; 396(1-2):295-305. PubMed ID: 25063221
    [Abstract] [Full Text] [Related]

  • 16. Circular RNA circ_HN1 facilitates gastric cancer progression through modulation of the miR-302b-3p/ROCK2 axis.
    Wang D, Jiang X, Liu Y, Cao G, Zhang X, Kuang Y.
    Mol Cell Biochem; 2021 Jan 23; 476(1):199-212. PubMed ID: 32949310
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Knockdown of linc00152 inhibits the progression of gastric cancer by regulating microRNA-193b-3p/ETS1 axis.
    Wang H, Chen W, Yang P, Zhou J, Wang K, Tao Q.
    Cancer Biol Ther; 2019 Jan 23; 20(4):461-473. PubMed ID: 30404587
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 28.